Concord Biotech Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 310 | 244 | 430 | 204 | 247 | 278 | 326 | 257 | |
| 10 | 15 | 9 | 14 | 13 | 10 | 15 | 13 | |
| 187 | 160 | 254 | 160 | 177 | 198 | 227 | 193 | |
| 68 | 61 | 80 | 60 | 57 | 67 | 71 | 70 | |
| 22 | 12 | 10 | 13 | 14 | 20 | 16 | 11 | |
| −13 | −21 | 38 | −28 | −22 | −21 | −0.40 | −27 | |
| 34 | 35 | 39 | 38 | 44 | 47 | 48 | 44 | |
| 0.10 | 0.10 | 0.10 | 0.06 | 0.06 | 0.08 | 0.08 | 0.04 | |
| 13 | 13 | 15 | 18 | 18 | 19 | 20 | 18 | |
| 64 | 59 | 72 | 60 | 65 | 66 | 74 | 77 | |
| 147 | 113 | 200 | 75 | 102 | 106 | 134 | 95 | |
| 133 | 99 | 185 | 57 | 83 | 87 | 114 | 77 | |
| — | — | — | — | — | −3 | — | — | |
| 133 | 99 | 185 | 57 | 83 | 87 | 114 | 77 | |
| 35 | 25 | 43 | 15 | 23 | 23 | 26 | 21 | |
| 96 | 76 | 140 | 44 | 63 | 64 | 88 | 58 | |
| Financial ratios | ||||||||
| 47.30% | 46.14% | 46.48% | 36.81% | 41.22% | 38.05% | 41.05% | 36.98% | |
| 30.87% | 31.09% | 32.66% | 21.60% | 25.52% | 22.91% | 27.13% | 22.41% | |
| 9.15 | 7.26 | 13.42 | 4.21 | 6.03 | 6.08 | 8.46 | 5.52 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.